Loading…
AtriCure entered a definitive agreement to acquire SentreHEART, a developer of left atrial appendage management solutions. The deal includes $40M upfront in cash and stock plus up to $260M in contingent consideration.
“We believe that SentreHEART is a strategic addition to AtriCure, significantly expanding our addressable markets with a product designed for electrophysiologists.”ir.atricure.com
Summarized from public sources; check the original articles before acting on it.